Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Clearside Biomedical Inc (CLSD)

Clearside Biomedical Inc (CLSD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Clearside Biomedical Inc 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 USA

www.clearsidebio.com Employees: 32 P: 678-270-3631

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space(TM) microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. Clearside Biomedical, Inc. is headquartered in Alpharetta, Georgia.

Key Statistics

Overview:

Market Capitalization, $K 2,146
Enterprise Value, $K -17,874
Shares Outstanding, K 5,234
Annual Sales, $ 1,660 K
Annual Net Income, $ -34,350 K
Last Quarter Sales, $ 200 K
Last Quarter Net Income, $ -5,970 K
EBIT, $ -22,820 K
EBITDA, $ -22,930 K
60-Month Beta 2.04
% of Insider Shareholders 6.70%
% of Institutional Shareholders 18.75%
Float, K 4,883
% Float 93.30%
Short Interest 757
Short Float 0.00%
Short Volume Ratio 0.58

Growth:

1-Year Return -97.45%
3-Year Return -97.72%
5-Year Return -98.72%
5-Year Revenue Growth -23.50%
5-Year Earnings Growth 41.93%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.14 on 11/14/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -5.19
EPS Growth vs. Prev Qtr -26.73%
EPS Growth vs. Prev Year 23.96%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 09/15/25

CLSD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -144.89%
Profit Margin % -2,069.28%
Debt/Equity 0.00
Price/Sales 1.77
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -10.30
Interest Coverage -2.51
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar